Cargando…

Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama

BACKGROUND: The current study evaluated the hypothesis that the COVID-19 pandemic is associated with higher stillbirth but lower neonatal mortality rates. METHODS: We compared three epochs: baseline (2016–2019, January–December, weeks 1–52, and 2020, January–February, weeks 1–8), initial pandemic (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Vivek V., Rahman, A. K. M. Fazlur, Shen, Xuejun, Black, Allison, Arora, Nitin, Lal, C. Vivek, Bell, Edward F., Nakhmani, Arie, Zhang, Chengcui, Ambalavanan, Namasivayam, Carlo, Waldemar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988197/
https://www.ncbi.nlm.nih.gov/pubmed/36879081
http://dx.doi.org/10.1038/s41390-023-02533-1
_version_ 1784901526960996352
author Shukla, Vivek V.
Rahman, A. K. M. Fazlur
Shen, Xuejun
Black, Allison
Arora, Nitin
Lal, C. Vivek
Bell, Edward F.
Nakhmani, Arie
Zhang, Chengcui
Ambalavanan, Namasivayam
Carlo, Waldemar A.
author_facet Shukla, Vivek V.
Rahman, A. K. M. Fazlur
Shen, Xuejun
Black, Allison
Arora, Nitin
Lal, C. Vivek
Bell, Edward F.
Nakhmani, Arie
Zhang, Chengcui
Ambalavanan, Namasivayam
Carlo, Waldemar A.
author_sort Shukla, Vivek V.
collection PubMed
description BACKGROUND: The current study evaluated the hypothesis that the COVID-19 pandemic is associated with higher stillbirth but lower neonatal mortality rates. METHODS: We compared three epochs: baseline (2016–2019, January–December, weeks 1–52, and 2020, January–February, weeks 1–8), initial pandemic (2020, March–December, weeks 9–52, and 2021, January–June, weeks 1–26), and delta pandemic (2021, July–September, weeks 27–39) periods, using Alabama Department of Public Health database including deliveries with stillbirths ≥20 weeks or live births ≥22 weeks gestation. The primary outcomes were stillbirth and neonatal mortality rates. RESULTS: A total of 325,036 deliveries were included (236,481 from baseline, 74,076 from initial pandemic, and 14,479 from delta pandemic period). The neonatal mortality rate was lower in the pandemic periods (4.4 to 3.5 and 3.6/1000 live births, in the baseline, initial, and delta pandemic periods, respectively, p < 0.01), but the stillbirth rate did not differ (9 to 8.5 and 8.6/1000 births, p = 0.41). On interrupted time-series analyses, there were no significant changes in either stillbirth (p = 0.11 for baseline vs. initial pandemic period, and p = 0.67 for baseline vs. delta pandemic period) or neonatal mortality rates (p = 0.28 and 0.89, respectively). CONCLUSIONS: The COVID-19 pandemic periods were not associated with a significant change in stillbirth and neonatal mortality rates compared to the baseline period. IMPACT: The COVID-19 pandemic could have resulted in changes in fetal and neonatal outcomes. However, only a few population-based studies have compared the risk of fetal and neonatal mortality in the pandemic period to the baseline period. This population-based study identifies the changes in fetal and neonatal outcomes during the initial and delta COVID-19 pandemic period as compared to the baseline period. The current study shows that stillbirth and neonatal mortality rates were not significantly different in the initial and delta COVID-19 pandemic periods as compared to the baseline period.
format Online
Article
Text
id pubmed-9988197
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-99881972023-03-07 Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama Shukla, Vivek V. Rahman, A. K. M. Fazlur Shen, Xuejun Black, Allison Arora, Nitin Lal, C. Vivek Bell, Edward F. Nakhmani, Arie Zhang, Chengcui Ambalavanan, Namasivayam Carlo, Waldemar A. Pediatr Res Population Study Article BACKGROUND: The current study evaluated the hypothesis that the COVID-19 pandemic is associated with higher stillbirth but lower neonatal mortality rates. METHODS: We compared three epochs: baseline (2016–2019, January–December, weeks 1–52, and 2020, January–February, weeks 1–8), initial pandemic (2020, March–December, weeks 9–52, and 2021, January–June, weeks 1–26), and delta pandemic (2021, July–September, weeks 27–39) periods, using Alabama Department of Public Health database including deliveries with stillbirths ≥20 weeks or live births ≥22 weeks gestation. The primary outcomes were stillbirth and neonatal mortality rates. RESULTS: A total of 325,036 deliveries were included (236,481 from baseline, 74,076 from initial pandemic, and 14,479 from delta pandemic period). The neonatal mortality rate was lower in the pandemic periods (4.4 to 3.5 and 3.6/1000 live births, in the baseline, initial, and delta pandemic periods, respectively, p < 0.01), but the stillbirth rate did not differ (9 to 8.5 and 8.6/1000 births, p = 0.41). On interrupted time-series analyses, there were no significant changes in either stillbirth (p = 0.11 for baseline vs. initial pandemic period, and p = 0.67 for baseline vs. delta pandemic period) or neonatal mortality rates (p = 0.28 and 0.89, respectively). CONCLUSIONS: The COVID-19 pandemic periods were not associated with a significant change in stillbirth and neonatal mortality rates compared to the baseline period. IMPACT: The COVID-19 pandemic could have resulted in changes in fetal and neonatal outcomes. However, only a few population-based studies have compared the risk of fetal and neonatal mortality in the pandemic period to the baseline period. This population-based study identifies the changes in fetal and neonatal outcomes during the initial and delta COVID-19 pandemic period as compared to the baseline period. The current study shows that stillbirth and neonatal mortality rates were not significantly different in the initial and delta COVID-19 pandemic periods as compared to the baseline period. Nature Publishing Group US 2023-03-06 /pmc/articles/PMC9988197/ /pubmed/36879081 http://dx.doi.org/10.1038/s41390-023-02533-1 Text en © The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Population Study Article
Shukla, Vivek V.
Rahman, A. K. M. Fazlur
Shen, Xuejun
Black, Allison
Arora, Nitin
Lal, C. Vivek
Bell, Edward F.
Nakhmani, Arie
Zhang, Chengcui
Ambalavanan, Namasivayam
Carlo, Waldemar A.
Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title_full Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title_fullStr Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title_full_unstemmed Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title_short Trends in fetal and neonatal outcomes during the COVID-19 pandemic in Alabama
title_sort trends in fetal and neonatal outcomes during the covid-19 pandemic in alabama
topic Population Study Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988197/
https://www.ncbi.nlm.nih.gov/pubmed/36879081
http://dx.doi.org/10.1038/s41390-023-02533-1
work_keys_str_mv AT shuklavivekv trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT rahmanakmfazlur trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT shenxuejun trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT blackallison trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT aroranitin trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT lalcvivek trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT belledwardf trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT nakhmaniarie trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT zhangchengcui trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT ambalavanannamasivayam trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama
AT carlowaldemara trendsinfetalandneonataloutcomesduringthecovid19pandemicinalabama